Investor Eye: Novalis Embraces Early Investment And Enabling Technology

Novalis Biotech employs early targeted investments to produce returns, focusing on enabling technologies and risky ventures in diagnostics and digital health.

Investor Eye Fetaure Image

More from Investor Eye

More from Business